110 related articles for article (PubMed ID: 1876600)
1. Effect of a new synthetic protease inhibitor on beta-endorphin release during acute pancreatitis in dogs.
Satake K; Hiura A; Ha SS; Nishiwaki H; Umeyama K
Pancreas; 1991 Jul; 6(4):441-7. PubMed ID: 1876600
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of a new synthetic protease inhibitor (E-3123) on hemodynamic changes during experimental acute pancreatitis in dogs.
Satake K; Ha SS; Hiura A; Nishiwaki H
Gastroenterol Jpn; 1993 Feb; 28(1):64-71. PubMed ID: 8440425
[TBL] [Abstract][Full Text] [Related]
3. Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis.
Satake K; Ha SS; Hiura A
Pancreas; 1996 Jan; 12(1):92-7. PubMed ID: 8927625
[TBL] [Abstract][Full Text] [Related]
4. Plasma beta-endorphin and the effect of naloxone on hemodynamic changes during experimental acute pancreatitis in dogs.
Satake K; Hiura A; Nishiwaki H; Ha SS; Chung YS; Umeyama K
Surg Gynecol Obstet; 1989 May; 168(5):402-6. PubMed ID: 2540537
[TBL] [Abstract][Full Text] [Related]
5. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
[TBL] [Abstract][Full Text] [Related]
6. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
9. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
Hirano T; Manabe T
J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
[TBL] [Abstract][Full Text] [Related]
10. Renal microcirculation in experimental acute pancreatitis of dogs.
Nishiwaki H; Ko I; Hiura A; Ha SS; Satake K; Sowa M
Ren Fail; 1993; 15(1):27-31. PubMed ID: 8441833
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
[TBL] [Abstract][Full Text] [Related]
12. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
13. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis.
Dobosz M; Sledziński Z; Basiński A; Stanek A; Babicki A; Wajda Z
Res Exp Med (Berl); 1989; 189(2):77-84. PubMed ID: 2499022
[TBL] [Abstract][Full Text] [Related]
14. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
Hirano T; Yotsumoto TM; Ando K; Tobe T
Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
[TBL] [Abstract][Full Text] [Related]
15. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
16. beta-Endorphin in canine hemorrhagic shock.
Tuggle DW; Horton JW
Surg Gynecol Obstet; 1986 Aug; 163(2):137-44. PubMed ID: 3016926
[TBL] [Abstract][Full Text] [Related]
17. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
Hirano T; Manabe T; Imanishi K; Tobe T
J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
Hirano T; Manabe T; Tobe T
Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
